stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Ceva Santé Animale

France · Privately owned

Ceva Santé Animale makes vaccines and health products for farm animals and pets.

Ceva Santé Animale is an animal health company. It makes vaccines and medicines for the animals people raise for food — poultry, pigs, and cattle — and for the pets sleeping on their sofas, mainly dogs and cats. Its customers are farmers, veterinarians, and pet owners, and the products are sold in more than a hundred countries.

The business runs on a simple idea: a chicken that stays healthy lays more eggs, and a pig that avoids disease grows into better pork. Vaccines are the heart of it. Preventing illness is usually cheaper for a farmer than treating it, and it helps keep antibiotic use down — a growing concern for regulators and consumers. Ceva also sells medicines that treat parasites and infections, plus products aimed at pets. Its biggest markets historically have been in Europe, but it has been expanding fast in the United States, Asia, and Latin America. Ceva is privately held and independent, which is unusual in this industry. Most of its rivals are divisions of giant drugmakers or public companies, including Merck through its animal health arm, Zoetis, Boehringer Ingelheim, and Elanco. Being private lets Ceva take a long view and chase growth through acquisitions, which it has done repeatedly — buying up smaller animal health businesses to build scale and reach. It is also known for a vaccine against a nasty pig virus and for spending heavily on research and development. The company's story goes back to a French veterinary laboratory founded in the late 1960s, with the Ceva name emerging in the 1980s. Today it is one of the larger players in global animal health, sitting behind the giants but competing hard on vaccines and on specific species like poultry and swine. It says it reinvests a big share of its profits back into research and development rather than paying out to outside shareholders.


The risks are real. Animal health is a slow-growth, competitive market where the big players have deeper pockets, and demand can swing with disease outbreaks, farming economics, and trade rules. A bird flu scare can lift vaccine sales one year and a farm downturn can cut them the next. Still, the core logic holds: as the world eats more meat and keeps more pets, someone has to keep those animals healthy. Ceva's pitch is that it does that job with vaccines, prevention, and a willingness to grow by buying its way into new markets.

Saved answer · last researched 15 Nov 2026